Results 211 to 220 of about 423,863 (309)
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier +7 more
wiley +1 more source
Changes in Seasonal Patterns of Pediatric Respiratory Viral Infections Before, During, and After the COVID-19 Pandemic: A Seventeen-Year Surveillance Study in the Republic of Korea. [PDF]
Oh MR, Han JS, Jeon JS, Kim JK.
europepmc +1 more source
The SARS‐CoV‐2 papain‐like protease (PLpro) is a medicinal chemistry target. Here we report mass spectrometry assays employing oligopeptide substrates based on the sequences of the viral polyproteins 1a/1ab and on an ISG15‐modified human protein, which enabled the identification of substrate‐selective PLpro inhibitors.
Sakshi Sharma +13 more
wiley +1 more source
Respiratory viral infections awaken metastatic breast cancer cells in lungs. [PDF]
Chia SB +28 more
europepmc +1 more source
ABSTRACT Aim Persistent high‐risk HPV infection can lead to the development of precancerous lesions, potentially progressing to invasive cancer. HPV status serves not only as a prognostic marker for squamous cell carcinoma (HNSCC) like oropharyngeal squamous cell carcinomas (OPSCC) but also significantly influences clinical management and treatment ...
Min Wang +9 more
wiley +1 more source
Intestinal-pulmonary axis: a 'Force For Good' against respiratory viral infections. [PDF]
Zhu J +5 more
europepmc +1 more source
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary +59 more
wiley +1 more source
Seasonal trends and year-on-year changes in vaccine-preventable respiratory viral infections: Insights from a tertiary care center in Thiruvananthapuram, India (2023-2024). [PDF]
Nair VB +4 more
europepmc +1 more source

